Occult hepatitis B virus infection
Loss of HBsAg antigen during treatment with entecavir or lamivudine in nucleoside-naïve HBeAg-positive patients with chronic hepatitis B*
Naturally occurring amino–acid substitutions to nucleos(t)ide analogues in treatment naive Turkish patients with chronic hepatitis B
Community-based hepatitis B screening programs in the United States in 2008
Long-term effectiveness and cost-effectiveness of antiviral treatment in hepatitis C
Hepatitis C virus-infected patients with a persistently normal alanine aminotransferase
Hepatitis C progressing to hepatocellular carcinoma
Longitudinal evaluation of viral interactions in treated HIV-hepatitis B co-infected patients with additional hepatitis C and D virus